Taking Mounjaro on Your Period: What the Evidence Says

What the licensed guidance actually says about timing your injection

The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, contains no instruction to avoid or delay an injection during menstruation. Neither does the NHS tirzepatide medicine page. Menstrual cycle phase is simply not a scheduling factor for this medicine. Your pen arrives on a weekly rhythm (in a plain, unbranded box with DPD tracking) and that rhythm does not pause for your cycle.

The SURMOUNT-1 trial, which enrolled 2,539 adults over 72 weeks and formed the backbone of tirzepatide's UK weight-management licence, did not identify any menstrual-phase variable as relevant to dosing safety or tolerability. Extrapolating from that data, the clinical position is straightforward: inject on your scheduled day, regardless of where you are in your cycle.

If you are uncertain about shifting your injection day for any reason (whether that is a planned trip or wanting to avoid the days you already feel worst) that is a conversation for your prescriber, not a decision to make unilaterally. A day's adjustment is unlikely to cause harm, but the right approach is always to check first.

Why some people feel worse on Mounjaro around their period

This is a genuine pattern, even though it is not formally documented in the prescribing literature. The mechanism is not mysterious. In the days before and during menstruation, oestrogen and progesterone levels shift, and for many people that shift brings nausea, bloating, cramping, fatigue and changes in appetite. Mounjaro's most common side effects (particularly nausea, gastrointestinal discomfort and tiredness) share that same territory. When two causes of nausea land in the same 48 hours, the combined experience can feel heavier than either on its own.

The NHS notes that gastrointestinal effects from tirzepatide are typically most pronounced after starting treatment or following a dose increase, then settle as the body adjusts. If your worst days consistently fall around your period, the pattern is worth noting and raising at your next clinical review. Your prescriber can consider whether timing, hydration support, or anti-nausea strategies help, guidance on managing nausea while on Mounjaro is also covered separately for those dealing with over-the-counter remedies alongside treatment.

Do not use a difficult period as a reason to skip your injection. Inconsistency in weekly dosing can affect how well the medicine works and may worsen tolerability when you restart.

The contraception point that cannot be skipped

This is the part of the conversation that genuinely matters if you use a combined oral contraceptive pill. Mounjaro slows gastric emptying, which can reduce how reliably oral medicines are absorbed. NHS England's guidance on weight-management injections advises that women taking oral contraceptives should use an additional non-oral method of contraception (such as condoms) for the first four weeks of Mounjaro treatment and for four weeks after every dose increase. This applies specifically to tirzepatide; the equivalent evidence for semaglutide is less clear-cut, but the caution for tirzepatide is explicit.

If you are already established on a stable Mounjaro dose and your pill absorption has not been flagged as a concern, this is less immediately pressing, but it is still worth confirming with your prescriber that your contraceptive method is suitable throughout your treatment. NHS England's guidance on weight-management injections covers this directly and is worth reading alongside any conversation you have about your cycle and your treatment.

Separately, Mounjaro is not recommended during pregnancy or breastfeeding, or for those actively trying to conceive. If your plans change, speak to a prescriber before your next injection rather than after.

Who can use Mounjaro and how a prescription works

Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The BMI eligibility criteria for Mounjaro are set out in detail if you want to check before starting a consultation.

Being on your period neither qualifies nor disqualifies you. Clinical suitability is determined by your overall health picture, not your cycle. A full breakdown of who Mounjaro is suitable for covers the medical history factors a prescriber weighs, including conditions that would require further discussion before treatment begins.

For those wondering about cost alongside eligibility, the context around Mounjaro pricing in the UK explains what a legitimate private prescription typically includes and why the lowest advertised figure is rarely the complete picture.

If you have questions specific to your situation, the right place to raise them is a clinical consultation. At nume, a GPhC-registered Independent Prescriber reads your answers the same day, a real clinician, not software. You can start a free consultation with our prescribers to discuss whether Mounjaro is appropriate for you and to get any cycle-related questions answered before your first pen arrives.